All Stories

  1. Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)

    Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

    Phoebe Thwaites

  2. Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease

    Article • Alimentary Pharmacology & Therapeutics, February 2017, Wiley

    Dr Gennaro Jim Rosella, Phoebe Thwaites, Mark Ward